M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Synthetic Biologics, Inc. to acquire VCN Biosciences
Announced Mar 11, 2022 · Closed Mar 11, 2022 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Synthetic Biologics, Inc. (SYN)
- Target
- VCN Biosciences
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Mar 11, 2022
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- A.G.P.
- To the target
- Tungsten Advisors
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations